Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Direxion Daily S&P 500 Bear 3X Shares ETF
SPXS
5
ProShares UltraPro Short S&P500 ETF
SPXU
US Stock MarketDetailed Quotes
TNYA Tenaya Therapeutics
- 0.5200
- +0.0100+1.96%
Close May 2 16:00 ET
- 0.5200
- 0.00000.00%
Post 20:01 ET
84.57MMarket Cap-0.40P/E (TTM)
0.5309High0.4952Low2.03MVolume0.4968Open0.5100Pre Close1.04MTurnover3.45%Turnover RatioLossP/E (Static)162.63MShares4.890052wk High0.91P/B30.68MFloat Cap0.394152wk Low--Dividend TTM59.00MShs Float32.0000Historical High--Div YieldTTM7.00%Amplitude0.3941Historical Low0.5090Avg Price1Lot Size
About Tenaya Therapeutics Company
Tenaya Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of therapeutics for cardiovascular diseases. It operates through its product platforms: gene therapy, cellular regeneration, and precision medicine. The company was founded by Deepak Srivastava, Benoit G. Bruneau, Bruce R. Conklin, Sheng Ding, Saptarsi Haldar, and Eric Olson in 2016 and is headquartered in South San Francisco, CA.
Company Profile
SymbolTNYA
Company NameTenaya Therapeutics
Listing DateJul 30, 2021
Issue Price15.00
Founded2016
CEOMr. Faraz Ali, M.B.A.
MarketNASDAQ
Employees97
Fiscal Year Ends12-31
Address171 Oyster Point Boulevard,5th floor, Suite 500
CitySouth San Francisco
ProvinceCalifornia
CountryUnited States of America
Zip Code94080
Phone1-650-825-6900
Company Executives
- Name
- Position
- Salary
- Faraz Ali, M.B.A.
- Director, Chief Executive Officer and Interim Principal Financial Officer
- 3.28M
- Dr. Whittemore Tingley, M.D.,PhD
- Chief Medical Officer
- 1.66M
- Tomohiro Higa
- Senior Vice President, Finance and Interim Principal Accounting Officer
- --
- Dr. Robert Sanders Willia M.D.
- Non-Executive Chairman of the Board
- 105.82K
- Karah Parschauer
- Independent Director
- 98.32K
- Amy Burroughs
- Independent Director
- 98.22K
- Jeffrey T. Walsh, M.B.A.
- Independent Director
- 110.82K
- Dr. June Lee, M.D.
- Independent Director
- 100.82K
- Dr. Deepak Srivastava, M.D.
- Independent Director
- 178.82K
- Dr. David V. Goeddel, PhD
- Independent Director
- 124.82K
- Dr. Catherine Stehman-Breen, M.D.
- Independent Director
- 100.82K
Market Insights
Discussing
BRK cash at new high: What to expect from Buffett’s meeting?
🎙️Discussion 1. Buffett said he won't sell Japanese stocks for the next ten years. What's your take? 2. In the face of market changes, do y
Moomoo News Global
Apr 28 18:10
Warren Buffett Stands Tall as U.S. Stocks Tumble: How the 'Oracle' Is Tackling Tariff Impacts
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
